Researcher's Profile

DA-LIANG OU (歐大諒)

     ORCID Follow

Research Outline     

MECHANISMS OF DRUG RESISTANCE OF HEPATOCELLULAR CARCINOMA (HCC) CELLS TO SORAFENIB AND OTHER MOLECULAR TARGETED THERAPY AND STRATEGIES TO OVERCOME THE RESISTANCE.